Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study

Clinical Biochemistry

Volumn 47, Issue 6, 2014, Pages 432-438

  Tohidi, Maryam ^a   Ghasemi, Asghar ^b,c   Hadaegh, Farzad ^a   Derakhshan, Arash ^a   Chary, Abdolreza ^a   Azizi, Fereidoun ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HOMA; Insulin; Reference values

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; LIPID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; HUMAN; IMMUNOASSAY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORMAL HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; REFERENCE VALUE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; WAIST CIRCUMFERENCE; YOUNG ADULT; AGE; BLOOD; GLUCOSE BLOOD LEVEL; HEALTH; METABOLISM; REGRESSION ANALYSIS; SEXUAL DEVELOPMENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; FASTING; FEMALE; HEALTH; HUMANS; INSULIN; INSULIN RESISTANCE; IRAN; LIPIDS; MALE; MIDDLE AGED; REFERENCE VALUES; REGRESSION ANALYSIS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84897115274     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.02.007     Document Type: Article

References (46)

1. Sacks D.B., Arnold M., Bakris G.L., Bruns D.E., Horvath A.R., Kirkman M.S., et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011, 57:e1-e47.
2. Chevenne D., Trivin F., Porquet D. Insulin assays and reference values. Diabetes Metab 1999, 25:459-476.
3. Cryer P.E. Hypoglycemia. Williams textbook of endocrinology 2011, 1552-1577. Saunders, Philadelphia. S. Melmed, K.S. Polonsky, P. Larsen, H.M. Kronenberg (Eds.).
4. Xun P., Wu Y., He Q., He K. Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2013, 98:1543-1554.
5. Haffner S.M., Miettinen H., Gaskill S.P., Stern M.P. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995, 44:1386-1391.
6. Weyer C., Hanson R.L., Tataranni P.A., Bogardus C., Pratley R.E. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 2000, 49:2094-2101.
7. Zavaroni I., Bonini L., Gasparini P., Barilli A., Zuccarelli A., Dall'Aglio E., et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism 1999, 48:989-994.
8. Dankner R., Chetrit A., Shanik M., Raz I., Roth J. Basal state hyperinsulinemia in healthy normoglycemic adults heralds dysglycemia after more than two decades of follow-up. Diabetes Metab Res Rev 2012, 28:618-624.
9. Francois A., Maumus S., Vincent-Viry M., Gueguen R., Siest G., Visvikis S. Age- and sex-related reference values for serum insulin concentration and its biological determinants in a French healthy population. The STANISLAS cohort. Clin Chem Lab Med 2004, 42:1140-1149.
10. Borai A., Livingstone C., Kaddam I., Ferns G. Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol 2011, 11:158.
11. Muniyappa R., Lee S., Chen H., Quon M.J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-E26.
12. Monzillo L.U., Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003, 61:397-412.
13. Lorenzo C., Hazuda H.P., Haffner S.M. Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart Study. J Clin Endocrinol Metab 2012, 97:793-799.
14. Kim C.H., Kim H.K., Kim E.H., Bae S.J., Park J.Y. Relative contributions of insulin resistance and β-cell dysfunction to the development of type 2 diabetes in Koreans. Diabet Med 2013, 30:1075-1079.
15. Vanhala P., Vanhala M., Kumpusalo E., Keinanen-Kiukaanniemi S. The quantitative insulin sensitivity check index QUICKI predicts the onset of type 2 diabetes better than fasting plasma insulin in obese subjects: a 5-year follow-up study. J Clin Endocrinol Metab 2002, 87:5834-5837.
16. Li S., Huang S., Mo Z.N., Gao Y., Yang X.B., Chen X.J., et al. Generating a reference interval for fasting serum insulin in healthy nondiabetic adult Chinese men. Singapore Med J 2012, 53:821-825.
17. Azizi F., Rahmani M., Emami H., Mirmiran P., Hajipour R., Madjid M., et al. Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (phase 1). Soz Praventivmed 2002, 47:408-426.
18. Azizi F., Ghanbarian A., Momenan A.A., Hadaegh F., Mirmiran P., Hedayati M., et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009, 10:5.
19. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
20. Azizi F., Khalili D., Aghajani H., Esteghamati A., Hosseinpanah F., Delavari A., et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med 2010, 13:243-244.
21. Horn P.S., Pesce A.J. Reference intervals: an update. Clin Chim Acta 2003, 334:5-23.
22. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
23. Horn P.S., Feng L., Li Y., Pesce A.J. Effect of outliers and nonhealthy individuals on reference interval estimation. Clin Chem 2001, 47:2137-2145.
24. Horn P.S., Pesce A.J., Copeland B.E. A robust approach to reference interval estimation and evaluation. Clin Chem 1998, 44:622-631.
25. Solberg H.E. Approved recommendation (1987) on the theory of reference values part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987, 25:645-656.
26. PetitClerc C., Solberg H.E. International Federation of Clinical Chemistry (IFCC), scientific committee, clinical section, expert panel on theory of reference values, and International Committee for Standardization in Haematology (ICSH), standing committee on reference values. Approved recommendation (1987) on the theory of reference values. Part 2. Selection of individuals for the production of reference values. J Clin Chem Clin Biochem 1987, 25:639-644.
27. Linnet K. Nonparametric estimation of reference intervals by simple and bootstrap-based procedures. Clin Chem 2000, 46:867-869.
28. American Diabetes Association Standards of medical care in diabetes-2011. Diabetes Care 2011, 34(Suppl. 1):S11-S61.
29. Gallois Y., Vol S., Caces E., Balkau B. Distribution of fasting serum insulin measured by enzyme immunoassay in an unselected population of 4,032 individuals. Reference values according to age and sex. D.E.S.I.R. Study Group. Donnees epidemiologiques sur le syndrome d'insulino-resistance. Diabetes Metab 1996, 22:427-431.
30. Kratz A., Ferraro M., Sluss P.M., Lewandrowski K.B. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med 2004, 351:1548-1563.
31. Dubuc G.R., Phinney S.D., Stern J.S., Havel P.J. Changes of serum leptin and endocrine and metabolic parameters after 7days of energy restriction in men and women. Metabolism 1998, 47:429-434.
32. Salazar M.R., Carbajal H.A., Espeche W.G., Leiva Sisnieguez C.E., Balbin E., Dulbecco C.A., et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol 2012, 109:1749-1753.
33. Ferrara A., Barrett-Connor E., Wingard D.L., Edelstein S.L. Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study, 1984-1987. Diabetes Care 1995, 18:220-225.
34. Pisprasert V., Ingram K.H., Lopez-Davila M.F., Munoz A.J., Garvey W.T. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African-Americans. Diabetes Care 2013, 36:845-853.
35. Harris E.K., Boyd J.C. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990, 36:265-270.
36. Clinical and Laboratory Standards Institute How to define and determine reference intervals in the clinical laboratory: approved guideline 2000, National Committee for Clinical Laboratory Standards. 2nd ed.
37. Lindeberg S., Eliasson M., Lindahl B., Ahren B. Low serum insulin in traditional pacific islanders-the Kitava study. Metabolism 1999, 48:1216-1219.
38. Bryhni B., Arnesen E., Jenssen T.G. Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study. BMC Endocr Disord 2010, 10:21.
39. Masharani U., Goldfine I.D., Youngren J.F. Influence of gender on the relationship between insulin sensitivity, adiposity, and plasma lipids in lean nondiabetic subjects. Metabolism 2009, 58:1602-1608.
40. Geloneze B., Repetto E.M., Geloneze S.R., Tambascia M.A., Ermetice M.N. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006, 72:219-220.
41. Geloneze B., Vasques A.C., Stabe C.F., Pareja J.C., Rosado L.E., Queiroz E.C., et al. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian metabolic syndrome study (BRAMS). Arq Bras Endocrinol Metabol 2009, 53:281-287.
42. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Targher G., et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998, 47:1643-1649.
43. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
44. Mehta N.N., Krishnamoorthy P., Martin S.S., St Clair C., Schwartz S., Iqbal N., et al. Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus. Am J Cardiol 2011, 107:406-411.
45. Gast K.B., Tjeerdema N., Stijnen T., Smit J.W., Dekkers O.M. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One 2012, 7:e52036.
46. Hansen A.M., Garde A.H., Eller N.H. Estimation of individual reference intervals in small sample sizes. Int J Hyg Environ Health 2007, 210:471-478.